DE3679255D1 - Behandlung chronischer entzuendungskrankheiten. - Google Patents

Behandlung chronischer entzuendungskrankheiten.

Info

Publication number
DE3679255D1
DE3679255D1 DE8686810340T DE3679255T DE3679255D1 DE 3679255 D1 DE3679255 D1 DE 3679255D1 DE 8686810340 T DE8686810340 T DE 8686810340T DE 3679255 T DE3679255 T DE 3679255T DE 3679255 D1 DE3679255 D1 DE 3679255D1
Authority
DE
Germany
Prior art keywords
chronic inflammatory
treatment
inflammatory diseases
disease
venously
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE8686810340T
Other languages
English (en)
Inventor
Alfred Haessig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCHWEIZ ROTES KREUZ
Original Assignee
SCHWEIZ ROTES KREUZ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10583453&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3679255(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by SCHWEIZ ROTES KREUZ filed Critical SCHWEIZ ROTES KREUZ
Application granted granted Critical
Publication of DE3679255D1 publication Critical patent/DE3679255D1/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8686810340T 1985-08-07 1986-07-29 Behandlung chronischer entzuendungskrankheiten. Revoked DE3679255D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858519848A GB8519848D0 (en) 1985-08-07 1985-08-07 Treatment of chronic inflammatory disease

Publications (1)

Publication Number Publication Date
DE3679255D1 true DE3679255D1 (de) 1991-06-20

Family

ID=10583453

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686810340T Revoked DE3679255D1 (de) 1985-08-07 1986-07-29 Behandlung chronischer entzuendungskrankheiten.

Country Status (10)

Country Link
US (1) US4676982A (de)
EP (1) EP0213072B1 (de)
JP (1) JPS6253931A (de)
AT (1) ATE63463T1 (de)
AU (1) AU599037B2 (de)
DE (1) DE3679255D1 (de)
DK (1) DK376386A (de)
GB (1) GB8519848D0 (de)
PH (1) PH21275A (de)
ZA (1) ZA865950B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0695189B1 (de) * 1992-12-29 1998-11-25 Genentech, Inc. Behandlung von entzündlichen darmerkrankungen mit interferon-gamma-inhibitoren
US6395273B1 (en) * 1998-06-10 2002-05-28 Promega Corporation Prevention and treatment of inflammatory bowel disease
US6767564B2 (en) * 2000-09-02 2004-07-27 The Trustees Of The University Of Pennsylvania Use of bowman birk inhibitor for the treatment of multiple sclerosis and other autoimmune diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH392780A (de) * 1961-12-07 1965-05-31 Schweiz Rotes Kreuz Verfahren zur Herstellung von intravenös anwendbaren Antikörperpräparaten humanen Ursprungs
JPS5296731A (en) * 1976-02-05 1977-08-13 Green Cross Corp:The Prophylactics and remedies of cyanomycosis
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
NZ201698A (en) * 1981-08-31 1985-12-13 S L Gaffin Composition of antibodies specific to endotoxins
EP0085747B2 (de) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
DK166763B1 (da) * 1983-03-16 1993-07-12 Immuno Ag Immunoglobulin-g-holdig fraktion
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
US4617266A (en) * 1983-04-28 1986-10-14 Genex Corporation Production of Protein A
CA1260828A (en) * 1983-07-04 1989-09-26 Masakazu Iwai Therapeutic and prophylactic agent for gastrointestinal ulcers
DE3340487A1 (de) * 1983-11-09 1985-05-15 Sandoz-Patent-GmbH, 7850 Lörrach Neue therapeutische verwendung

Also Published As

Publication number Publication date
EP0213072B1 (de) 1991-05-15
AU6089086A (en) 1987-02-12
EP0213072A3 (en) 1987-09-30
DK376386A (da) 1987-02-08
AU599037B2 (en) 1990-07-12
US4676982A (en) 1987-06-30
ATE63463T1 (de) 1991-06-15
GB8519848D0 (en) 1985-09-11
EP0213072A2 (de) 1987-03-04
PH21275A (en) 1987-09-28
ZA865950B (en) 1988-03-30
DK376386D0 (da) 1986-08-06
JPS6253931A (ja) 1987-03-09

Similar Documents

Publication Publication Date Title
ES510042A0 (es) "un procedimiento de preparacion de nuevas carboxamidas heterociclicas".
DE69129800T2 (de) Behandlung von menschlichen retrovirus-infektionen mit 2',3'-dideoxyinosin
JPS57193412A (en) Prevention of prostatic hyperplasia and therapeutical drug
DK0564505T3 (da) Administrationsform til mikroblæreekkokontrastmidler
DE3587741T2 (de) Behandlung von Hautkrankheiten.
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
IT8267970A0 (it) Dispositivo per la somministrazione per via parenterale di agenti benefici particolarmente sangue e suoi sostituti
DE3872754T2 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
DE3777861D1 (de) Behandlung von gasen.
DE69118978D1 (de) Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen
DE69110713T2 (de) 7-Oxabicycloheptan-imidazol-prostaglandin-Analoge, verwendbar bei der Behandlung von thrombotischen und vasospastischen Erkrankungen.
SE7900136L (sv) Flytbarhetshjelpmedel
EP0339163A3 (en) Monoclonal antibodies specific for hiv and hybridomas for their production
DK0413329T3 (da) 5-methyl-isoxazol-4-carboxylsyreanilider og 2-hydroxyethyliden-cyaneddikesyreanilider til behandling af øjensygdomme
DE3679255D1 (de) Behandlung chronischer entzuendungskrankheiten.
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
IT7822027A0 (it) Apparecchio medicale per la cura della trombosi venale profonda.
NO883603D0 (no) Humane monoklonale antistoffer og profylaktiske og terapeutiske midler mot infektioese sykdommer inneholdende disse som effektiv bestanddel.
DE3876425T2 (de) Gesteuerte verabreichung eines heilmittels an blut.
SE8306384D0 (sv) Farmaceutisk komposition
DE3668338D1 (de) Kontinuierliche behandlung von spannungslosem gewebe.
IT8148480A0 (it) Composizione terapeutica e sistema per il trattamento extracorporeo di sangue intero
DE69006964T2 (de) Behandlung von Hyperlipidemia mit 15-keto-Prostaglandin-Verbindungen.
ATE63731T1 (de) Behandlung von gasstroemen.

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Free format text: SPOTT, G., DIPL.-CHEM. DR.RER.NAT. LEISSLER-GERSTL, G., PAT.-ANWAELTE, 8000 MUENCHEN

8363 Opposition against the patent
8331 Complete revocation